Stay updated on Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page.

Latest updates to the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical trial for IPH2201 and cetuximab in head and neck cancer, including detailed study objectives and inclusion/exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference20%
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference2%
- Check96 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page.